Another study has revealed that WWC1 cooperated with NF2 to mitigate the malignant progression of intrahepatic cholangiocarcinoma by activation of LATS1/2 and inhibition of YAP/TAZ activity [23]. The gene discussed is LATS1; the disease is intrahepatic cholangiocarcinoma.